National Institutes of Health logo
NIH Exploratory/Developmental Research Grant

Cutting-Edge Basic Research Awards (CEBRA)

Funds high-risk addiction research that is sparse or absent from the institute's current portfolio — a revolutionary method, or a hypothesis with no precedent.

Most funding rewards work that resembles work already funded. This award is written to do the opposite, and it says so explicitly.

The institute is looking for highly innovative or conceptually creative research on the causes, mechanisms, prevention or treatment of substance use disorders. The test is stated as an absence: research that is sparse or not included in the institute's current portfol

Highly innovative, high-risk research on the aetiology, pathophysiology, prevention or treatment of substance use disorders that is sparse or absent from the institute's current portfolio, either developing or adapting revolutionary techniques and methods, or testing a significant hypothesis with scant precedent or preliminary data that would transform current thinking if confirmed. Clinical trials are optional.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.11 Aug 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.
Funding pooliThe total budget available across all awards in this round.$150K

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: PAR-25-101Source: www.grants.gov